Form 8-K - Current report:
SEC Accession No. 0001193125-22-296035
Filing Date
2022-12-01
Accepted
2022-12-01 09:23:08
Documents
12
Period of Report
2022-11-30
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K d404005d8k.htm   iXBRL 8-K 27432
  Complete submission text file 0001193125-22-296035.txt   150066

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA txmd-20221130.xsd EX-101.SCH 2871
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE txmd-20221130_lab.xml EX-101.LAB 17994
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE txmd-20221130_pre.xml EX-101.PRE 11275
6 EXTRACTED XBRL INSTANCE DOCUMENT d404005d8k_htm.xml XML 3347
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

EIN.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-00100 | Film No.: 221437574
SIC: 2834 Pharmaceutical Preparations